BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2842081)

  • 1. Fusarium moniliforme metabolites: genotoxicity of culture extracts.
    Lu SJ; Ronai ZA; Li MH; Jeffrey AM
    Carcinogenesis; 1988 Sep; 9(9):1523-7. PubMed ID: 2842081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, structural identification, and characterization of a mutagen from Fusarium moniliforme.
    Lu FX; Jeffrey AM
    Chem Res Toxicol; 1993; 6(1):91-6. PubMed ID: 8448356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation and deactivation of fusarin C, a mutagen produced by Fusarium moniliforme.
    Gelderblom WC; Thiel PG; van der Merwe KJ
    Biochem Pharmacol; 1984 May; 33(10):1601-3. PubMed ID: 6732833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of fusarin C by rat liver microsomes. Role of esterase and cytochrome P-450 enzymes with respect to the mutagenicity of fusarin C in Salmonella typhimurium.
    Lu SJ; Li MH; Park SS; Gelboin HV; Jeffrey AM
    Biochem Pharmacol; 1989 Nov; 38(21):3811-7. PubMed ID: 2512928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxicity of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): formation of 2-hydroxamino-PhIP, a directly acting genotoxic metabolite.
    Holme JA; Wallin H; Brunborg G; Søderlund EJ; Hongslo JK; Alexander J
    Carcinogenesis; 1989 Aug; 10(8):1389-96. PubMed ID: 2665964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutagenic metabolite produced by Fusarium moniliforme isolated from Linxian county, China.
    Cheng SJ; Jiang YZ; Li MH; Lo HZ
    Carcinogenesis; 1985 Jun; 6(6):903-5. PubMed ID: 4006077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusarin C: isolation and identification of two microsomal metabolites.
    Zhu B; Jeffrey AM
    Chem Res Toxicol; 1993; 6(1):97-101. PubMed ID: 8448357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on the carcinogenicity of fusarin C--a mutagenic metabolite of Fusarium moniliforme.
    Gelderblom WC; Thiel PG; Jaskiewicz K; Marasas WF
    Carcinogenesis; 1986 Nov; 7(11):1899-901. PubMed ID: 2876785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on a new mutagen produced by fusarium moniliforme isolated in Linxian County].
    Cheng SJ
    Zhonghua Zhong Liu Za Zhi; 1985 Sep; 7(5):321-3. PubMed ID: 4092572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA adduct formation by Fusarium culture extracts: lack of role of fusarin C.
    Bever RJ; Couch LH; Sutherland JB; Williams AJ; Beger RD; Churchwell MI; Doerge DR; Howard PC
    Chem Biol Interact; 2000 Oct; 128(2):141-57. PubMed ID: 11024453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity of naturally occurring indole compounds: correlation between covalent DNA binding and other genotoxicity tests.
    Reddy MV; Storer RD; Laws GM; Armstrong MJ; Barnum JE; Gara JP; McKnight CG; Skopek TR; Sina JF; DeLuca JG; Galloway SM
    Environ Mol Mutagen; 2002; 40(1):1-17. PubMed ID: 12211071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ).
    Brunborg G; Holme JA; Alexander J; Becher G; Hongslo JK
    Mutagenesis; 1988 Jul; 3(4):303-9. PubMed ID: 3062317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selected secondary metabolites of Fusarium moniliforme on unscheduled synthesis of DNA by rat primary hepatocytes.
    Norred WP; Plattner RD; Vesonder RF; Bacon CW; Voss KA
    Food Chem Toxicol; 1992 Mar; 30(3):233-7. PubMed ID: 1618447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity, metabolism and DNA adduct formation of 6-nitrochrysene in Salmonella typhimurium.
    el-Bayoumy K; Delclos KB; Heflich RH; Walker R; Shiue GH; Hecht SS
    Mutagenesis; 1989 May; 4(3):235-40. PubMed ID: 2659942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of biotransformation products of disperse dyes with rat liver microsomes by LC-MS/MS and theoretical studies with DNA: Structure-mutagenicity relationship using Salmonella/microsome assay.
    Franco JH; Silva BFD; Oliveira RV; Meireles G; de Oliveira DP; Castro AA; Ramalho TC; Zanoni MVB
    Sci Total Environ; 2018 Feb; 613-614():1093-1103. PubMed ID: 28950671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
    Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mutagenicity and calf thymus DNA adducts formed by the particulate and semivolatile fractions of vehicle exhausts.
    Pohjola SK; Lappi M; Honkanen M; Savela K
    Environ Mol Mutagen; 2003; 42(1):26-36. PubMed ID: 12874810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of metabolic activation for four mutagens in a bacterial, fungal and two mammalian cell mutagenesis assays.
    Rees RW; Brice AJ; Carlton JB; Gilbert PJ; Mitchell ID
    Mutagenesis; 1989 Sep; 4(5):335-42. PubMed ID: 2687626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.